Clinical Trial Update: Safety and Pharmacokinetics of IV CR845 in Hemodialysis Patients, and Its Efficacy in Patients With Uremic Pruritus [Phase 2]

View source ↗

Summary

Phase 2 study evaluating safety, pharmacokinetics, and preliminary efficacy of intravenous CR845 (difelikefalin) in hemodialysis patients with uremic pruritus; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pruritus
• Uremic Pruritus

Drugs mentioned

• CR845 (difelikefalin)

Snippet

Sponsor: Cara Therapeutics, Inc. | Conditions: Pruritus, Uremic Pruritus | Phase 2 | Status: COMPLETED